Data-driven platform for translational research
The Euretos platform empowers translational scientists involved in basic disease research and drug development. By seamlessly integrating a vast array of data sources including literature, patents, experimental and real-world patient data, our platform offers an unparalleled resource for discovering new drug targets and understanding disease mechanisms.
Unique AI-integrated knowledge base
Access a unique, AI integrated biomolecular knowledge graph linking multi-omics data to literature, patents, experimental and clinical evidence. Assess key aspects such as multi-omics interactions, gene expression in tissues, cell types and tumors, pathway interactions, regulatory and signalling responses, gene variants, clinical trials, target tractability and patents.
Portal - Powerful, high-impact workflows
| Identify disease markers & targets | Rank targets for a disease
| Single cell target expression | BioProfile through Enrichment analysis
| Assess marker & target candidate | Structured literature review
| Target identification in cancer | Single cell study viewer
| Cancer cell line identifier | Tailored workflows
Search - Optimised for disease biology
| Gene Detail Page
| Gene-Disease Analysis
| Set Creation.
Analytics - Systems biological insights
| Gene Set Enrichment
| Gene Set Ranking
| Heatmap Analysis
Knowledge Graph - Biological interaction analysis
"The Euretos Knowledge Platform is nothing less than an in silico way to save all drug and biotech researchers an infinite amount of blood, sweat and tears by providing them with a powerful knowledge discovery platform. The Euretos Knowledge Platform allows the researcher to rapidly assess whether a given target, research area, etc., is related, even distantly, to another such entity thus allowing one to uncover hidden connections, leading to new knowledge. In the drug discovery arena, this thing is a gold mine."
"One of the key aims of our project is to create Covid19 disease model which is based on real world and clinical observations and rationalised and validated by Covid19 disease experts and clinicians. The Euretos AI Platform plays an essential role in this rationalisation process and will be the initial starting point for creating the Covid19 in silico disease model."
""I find the AskEuretos platform to be valuable in what it offers in terms of advanced AI capabilities and analytics of smart scouting and literature searches to probe relevant targets, indications, and therapeutics. The professional support and dedicated mentoring from experienced bioinformatics professionals that Euretos offers greatly enhances our ability to take advantage of all the capabilities of the platform, and extract meaningful insights for our day-to-day mission of bringing innovation into Teva.""
Keep up with our latest news and events. Sign up for our newsletter.